Skip Navigation

Annals of Oncology 2009 20(12):1903; doi:10.1093/annonc/mdp543
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org

in this issue

in this issue

The first 10% of the full text of this article appears below.


   core needle biopsy and excisional biopsy for receptor status in early breast cancer
 
The status of estrogen receptor (ER), progesterone receptor (PgR) and HER2 is critical in the management of patients with invasive breast carcinoma. The accuracy of core needle biopsy (CNB) for the diagnosis of breast carcinoma has been extensively studied and good concordance rate have been reported between it and excisional biopsy (EB). However, the possibility of . . . [Full Text of this Article]


   adjuvant 5-fluorouracil/folinic acid versus FOLFIRI following resection of liver metastases from colorectal cancer
 

   high-dose CHOP plus etoposide in T-cell lymphoma
 

   acenocumarine or dalteparin for the prevention of central vein catheter-related thrombosis
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?